BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7797554)

  • 1. Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells.
    Schmitz ML; dos Santos Silva MA; Baeuerle PA
    J Biol Chem; 1995 Jun; 270(26):15576-84. PubMed ID: 7797554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    Schmitz ML; Baeuerle PA
    EMBO J; 1991 Dec; 10(12):3805-17. PubMed ID: 1935902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation.
    Schmitz ML; dos Santos Silva MA; Altmann H; Czisch M; Holak TA; Baeuerle PA
    J Biol Chem; 1994 Oct; 269(41):25613-20. PubMed ID: 7929265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NF-kappa B p65 promoter.
    Ueberla K; Lu Y; Chung E; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):227-30. PubMed ID: 8450395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B p65 transactivation domain is involved in the NF-kappa B-inducing kinase pathway.
    Jiang X; Takahashi N; Ando K; Otsuka T; Tetsuka T; Okamoto T
    Biochem Biophys Res Commun; 2003 Feb; 301(2):583-90. PubMed ID: 12565903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536.
    Jiang X; Takahashi N; Matsui N; Tetsuka T; Okamoto T
    J Biol Chem; 2003 Jan; 278(2):919-26. PubMed ID: 12419817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel.
    Martin AG; Fresno M
    J Biol Chem; 2000 Aug; 275(32):24383-91. PubMed ID: 10823840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.
    Wang D; Baldwin AS
    J Biol Chem; 1998 Nov; 273(45):29411-6. PubMed ID: 9792644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
    Madrid LV; Mayo MW; Reuther JY; Baldwin AS
    J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.
    Zhong H; Voll RE; Ghosh S
    Mol Cell; 1998 Apr; 1(5):661-71. PubMed ID: 9660950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.
    Buss H; Dörrie A; Schmitz ML; Hoffmann E; Resch K; Kracht M
    J Biol Chem; 2004 Dec; 279(53):55633-43. PubMed ID: 15489227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunit.
    Asamitsu K; Tetsuka T; Kanazawa S; Okamoto T
    J Biol Chem; 2003 Jul; 278(29):26879-87. PubMed ID: 12748188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif.
    Phares W; Franza BR; Herr W
    J Virol; 1992 Dec; 66(12):7490-8. PubMed ID: 1331533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.
    Roulston A; Beauparlant P; Rice N; Hiscott J
    J Virol; 1993 Sep; 67(9):5235-46. PubMed ID: 8394446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
    Cressman DE; Taub R
    Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.